Saturday 01 Oct, 2022 04:14 AM
Site map | Locate Us | Login
   Dilip Buildcon gains on emerging as L-1 bidder for Rs 723-cr project    Dish TV India Ltd leads losers in 'A' group    Akshar Spintex Ltd leads losers in 'B' group    Goa Carbon temporarily shuts Goa unit    Volumes spurt at Caplin Point Laboratories Ltd counter    Mahindra & Mahindra Ltd soars 1.16%    Punjab & Sind Bank gains for third consecutive session    Indian Overseas Bank gains for third straight session    Sun Pharmaceuticals Industries Ltd spurts 1.46%, rises for third straight session    HCL Technologies Ltd gains for fifth session    Bajaj Finance gains on bargain buying    Heritage Foods spurts after board approves rights issue     CMI Ltd leads gainers in 'B' group    Zydus Lifesciences arm gets 2 observations from USFDA    Nestle India ED and CFO David McDaniel resigns 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Cipla board appoints Ashish Adukia as global CFO
17-Aug-22   10:25 Hrs IST

The drug maker said that the new appointment will relieve Dinesh Jain from the additional responsibility of interim chief financial officer with effect from 16 August 2022. Dinesh Jain will continue as senior vice-president & head-corporate finance, it added.

Ashish Adukia has close to two decades of experience spanning across investment banking and a large Indian conglomerate. In his earlier assignment, Adukia was the chief financial officer of Grasim Industries, the flagship company of the Aditya Birla Group (ABG) and was part of the leadership team. Prior to ABG, he has worked as an investment banker with organizations like Morgan Stanley, Citigroup and PwC.

Ashish Adukia is a Chartered Accountant and MMS (Finance) from JBIMS. In 2017, he featured in Fortune India's 40 under 40 list.

Cipla is a global pharmaceutical company focused on agile and sustainable growth, complex generics, and deepening portfolio in our home markets of India, South Africa, North America, and key regulated and emerging markets.

The company's consolidated net profit slipped 4% to Rs 686.40 crore on 2.3% decline in total revenue from operations to Rs 5,375.19 crore in Q1 FY23 over Q1 FY22.

Shares of Cipla were down 0.18% to Rs 1,032 on the BSE.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 22552087
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016  |  MCX : INZ000081736
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 12815 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. Saravana Stocks Pvt. Ltd